The DOI matches its Crossref record; 6 of the 10 references it cites were found in a registry or an index.
Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014
Open accessAbstract
The United States is experiencing an epidemic of drug overdose (poisoning) deaths. Since 2000, the rate of deaths from drug overdoses has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). CDC analyzed recent multiple cause-of-death mortality data to examine current trends and characteristics of drug overdose deaths, including the types of opioids associated with drug overdose deaths. During 2014, a total of 47,055 drug overdose deaths occurred in the United States, representing a 1-year increase of 6.5%, from 13.8 per 100,000 persons in 2013 to 14.7 per 100,000 persons in 2014. The rate of drug overdose deaths increased significantly for both sexes, persons aged 25-44 years and ≥55 years, non-Hispanic whites and non-Hispanic blacks, and in the Northeastern, Midwestern, and Southern regions of the United States. Rates of opioid overdose deaths also increased significantly, from 7.9 per 100,000 in 2013 to 9.0 per 100,000 in 2014, a 14% increase. Historically, CDC has programmatically characterized all opioid pain reliever deaths (natural and semisynthetic opioids, methadone, and other synthetic opioids) as "prescription" opioid overdoses (1). Between 2013 and 2014, the age-adjusted rate of death involving methadone remained unchanged; however, the age-adjusted rate of death involving natural and semisynthetic opioid pain relievers, heroin, and synthetic opioids, other than methadone (e.g., fentanyl) increased 9%, 26%, and 80%, respectively. The sharp increase in deaths involving synthetic opioids, other than methadone, in 2014 coincided with law enforcement reports of increased availability of illicitly manufactured fentanyl, a synthetic opioid; however, illicitly manufactured fentanyl cannot be distinguished from prescription fentanyl in death certificate data. These findings indicate that the opioid overdose epidemic is worsening. There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Opioids accounted for 61% of all drug-related overdoses in 2014 (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
In the citing paper
“Between 2000 and 2014, nearly a half million people in the US died from a drug overdose (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
Citations
Cites
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350
The Changing Face of Heroin Use in the United States
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.366 · Cited by 1,169
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,014
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.
Jones, C. M., Logan, J. E., Gladden, R. M., & Bohm, M. K. (2015) · PubMed Central · Cited by 476
Injury in the United States; 2007 chartbook
Bergen, G., Chen, L., & Warner, M. (2008) · Cited by 120
Davis, G. G. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0323-x · Cited by 99
Cited by
Sorted by citations
Items 301–400 of 1,001
Dev, R., Kim, Y. J., Reddy, A. S., Hui, D., Tanco, K. C., Liu, D., Park, M., Williams, J. L., Carmack, C. L., & Bruera, E. D. (2018) · Cancer · doi:10.1002/cncr.31783 · Cited by 61
Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005–2016
Fischer, B. (2018) · Pain Physician · doi:10.36076/ppj.2018.3.219 · Cited by 61
Ilan, Y. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081303 · Cited by 63
Bounthavong, M., Harvey, M., Wells, D. L., Popish, S. J., Himstreet, J. E., Oliva, E. M., Kay, C. L., Lau, M. K., Randeria-Noor, P. P., Phillips, A. G., et al. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.11.003 · Cited by 61
Drug involvement in fatal overdoses
Ruhm, C. J. (2017) · SSM - Population Health · doi:10.1016/j.ssmph.2017.01.009 · Cited by 62
Green, J. L., Bartelson, B. B., Lait, M. C. L., Roland, C. L., Masters, E. T., Mardekian, J., Bailey, J. E., & Dart, R. C. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.01.039 · Cited by 61
The societal cost of heroin use disorder in the United States
Jiang, R., Lee, I.-Y., Lee, T. A., & Pickard, A. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177323 · Cited by 61
Langabeer, J. R., Gourishankar, A., Chambers, K. A., Giri, S., Madu, R., & Champagne‐Langabeer, T. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000523 · Cited by 61
Meisel, Z. F., Lupulescu‐Mann, N., Charlesworth, C. J., Kim, H., & Sun, B. (2019) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2019.04.007 · Cited by 61
Comorbidity of opioid-related and anxiety-related symptoms and disorders
Langdon, K. J., Dove, K., & Ramsey, S. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.12.020 · Cited by 53
Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids
Nielsen, S., Larance, B., & Lintzeris, N. (2017) · JAMA · doi:10.1001/jama.2017.0001 · Cited by 60
“Comparisons: (1) Different opioid agonist maintenance treatments (methadone vs buprenorphine) and (2) maintenance treatment (buprenorphine) vs opioid taper and vs psychological treatment alone.”
BackgroundClinical Pharmacology, Toxicity, and Abuse Potential of Opioids
Vearrier, D., & Grundmann, O. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1923 · Cited by 69
Clinical pain management: Current practice and recent innovations in research
Wang, J., & Doan, L. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101786 · Cited by 74
Music as an Adjunct to Opioid-Based Analgesia
Chai, P. R., Carreiro, S., Ranney, M. L., Karanam, K., Ahtisaari, M., Edwards, R. R., Schreiber, K. L., Ben-Ghaly, L., Erickson, T. B., & Boyer, E. W. (2017) · Journal of Medical Toxicology · doi:10.1007/s13181-017-0621-9 · Cited by 66
From Mechanism to Cure: Renewing the Goal to Eliminate the Disease of Pain
Price, T. J., & Gold, M. S. (2017) · Pain Medicine · doi:10.1093/pm/pnx108 · Cited by 58
US Employment and Opioids: Is There a Connection?
Currie, J., Jin, J., & Schnell, M. K. (2019) · Emerald Group Publishing Limited eBooks · doi:10.1108/s0147-912120190000047009 · Cited by 60
Murphy, D. L., Lebin, J. A., Severtson, S. G., Olsen, H. A., Dasgupta, N., & Dart, R. C. (2018) · Drug Safety · doi:10.1007/s40264-018-0660-4 · Cited by 59
Perioperative use of opioids: Current controversies and concerns
Alexander, J. C., Patel, B. T., & Joshi, G. P. (2019) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2019.07.009 · Cited by 61
Fredriksson, I., Applebey, S. V., Minier-Toribio, A. M., Shekara, A., Bossert, J. M., & Shaham, Y. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0602-6 · Cited by 58
The opioid epidemic in pediatrics: a 2020 update
Yaster, M., McNaull, P. P., & Davis, P. J. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000865 · Cited by 56
Advances in the delivery of buprenorphine for opioid dependence
Rosenthal, R. N., & Goradia, V. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s72543 · Cited by 59
Miller, A. C., & Polgreen, P. M. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy632 · Cited by 59
Stone, A. C., Carroll, J. J., Rich, J. D., & Green, T. C. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108031 · Cited by 58
Strumpf, E., Charters, T. J., Harper, S. B., & Nandi, A. (2017) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.07.016 · Cited by 59
Fatality Following Ingestion of Tetrahydrofuranylfentanyl, U-49900 and Methoxy-Phencyclidine
Krotulski, A. J., Papsun, D. M., Friscia, M., Swartz, J., Holsey, B. D., & Logan, B. K. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx092 · Cited by 59
The Epidemic as Stigma: The Bioethics of Opioids
Buchman, D. Z., Leece, P., & Orkin, A. M. (2017) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110517750600 · Cited by 63
A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic
Cerdá, M., Krawczyk, N., Hamilton, L., Rudolph, K. E., Friedman, S. R., & Keyes, K. M. (2020) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102727 · Cited by 61
Potentially Preventable Deaths Among the Five Leading Causes of Death — United States, 2010 and 2014
García, M. C., Bastian, B. A., Rossen, L. M., Anderson, R. N., Miniño, A., Yoon, P. W., Faul, M., Massetti, G. M., Thomas, C. C., Hong, Y., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6545a1 · Cited by 57
Berland, N., Fox, A. D., Tofighi, B., & Hanley, K. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1275925 · Cited by 57
Prevalence of Long‐Term Opioid Use in Long‐Stay Nursing Home Residents
Hunnicutt, J. N., Chrysanthopoulou, S. A., Ulbricht, C. M., Hume, A. L., Tjia, J., & Lapane, K. L. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15080 · Cited by 56
Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada
MacDougall, L., Smolina, K., Otterstatter, M. C., Zhao, B., Chong, M., Godfrey, D. M., Mussavi-Rizi, A., Sutherland, J., Kuo, M. E., & Kendall, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210129 · Cited by 57
Galaj, E., Newman, A. H., & Xi, Z. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.024 · Cited by 56
Schneider, K. E., Park, J. N., Allen, S. T., Weir, B. W., & Sherman, S. G. (2020) · Public Health Reports · doi:10.1177/0033354920915439 · Cited by 55
Good Samaritan laws and overdose mortality in the United States in the fentanyl era
Hamilton, L., Davis, C. S., Kravitz‐Wirtz, N., Ponicki, W. R., & Cerdá, M. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103294 · Cited by 56
Update on the Pharmacology and Legal Status of Kratom
Prozialeck, W. C. (2016) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2016.156 · Cited by 55
Therapeutic efficacy of environmental enrichment for substance use disorders
Galaj, E., Barrera, E. D., & Ranaldi, R. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172829 · Cited by 58
Johnson, A. A., Berry, A., Bradley, M., Daniell, J. A., Lugo, C., Schaum-Comegys, K., Villamero, C., Williams, K., Yi, H., Scala, E., et al. (2021) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2021.02.007 · Cited by 55
Cerdá, M., Ponicki, W. R., Smith, N., Rivera‐Aguirre, A., Davis, C. S., Marshall, B. D. L., Fink, D. S., Henry, S. G., Castillo‐Carniglia, Á., Wintemute, G. J., et al. (2019) · Epidemiology · doi:10.1097/ede.0000000000001123 · Cited by 55
The Past, Present, and Future of PrEP implementation Among People Who Use Drugs
Biello, K. B., Mimiaga, M. J., Valente, P. K., Saxena, N., & Bazzi, A. R. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00556-z · Cited by 57
Group-based treatment of opioid use disorder with buprenorphine: A systematic review
Sokol, R., LaVertu, A. E., Morrill, D., Albanese, C., & Schuman-Olivier, Z. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.11.003 · Cited by 50
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
Martins, S. S., Ponicki, W. R., Smith, N., Rivera‐Aguirre, A., Davis, C. S., Fink, D. S., Castillo‐Carniglia, Á., Henry, S. G., Marshall, B. D. L., Gruenewald, P. J., et al. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.10.001 · Cited by 54
Hurstak, E., Kushel, M., Chang, J. S., Ceasar, R. C., Zamora, K. A., Miaskowski, C. A., & Knight, K. R. (2017) · Substance Abuse · doi:10.1080/08897077.2017.1296524 · Cited by 55
Risk factors for severe respiratory depression from prescription opioid overdose
Fox, L. M., Hoffman, R. S., Vlahov, D., & Manini, A. F. (2017) · Addiction · doi:10.1111/add.13925 · Cited by 55
Guillen, A., Reddy, M., Saadat, S., & Chakravarthy, B. (2021) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2021.0308 · Cited by 54
Brinkley‐Rubinstein, L., Cloud, D. H., Davis, C., Zaller, N. D., Delany‐Brumsey, A., Pope, L. G., Martino, S., Bouvier, B., & Rich, J. D. (2017) · International Journal of Prisoner Health · doi:10.1108/ijph-08-2016-0039 · Cited by 60
The Opioid Crisis and Its Consequences
Weiner, S. G., Malek, S. K., & Price, C. N. (2017) · Transplantation · doi:10.1097/tp.0000000000001671 · Cited by 53
DSM-5 substance use disorders among adult primary care patients: Results from a multisite study
Wu, L.-T. T., McNeely, J., Subramaniam, G., Brady, K. T., Sharma, G., VanVeldhuisen, P., Zhu, H., & Schwartz, R. P. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.048 · Cited by 54
Difficulties in emotion regulation and chronic pain-related disability and opioid misuse
Lutz, J., Gross, R. T., & Vargovich, A. M. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.07.018 · Cited by 53
Stone, A. C., Carroll, J. J., Rich, J. D., & Green, T. C. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.019 · Cited by 53
Lippold, K. M., & Ali, B. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108059 · Cited by 56
Alpert, A. E., Powell, D., & Pacula, R. L. (2017) · National Bureau of Economic Research · doi:10.3386/w23031 · Cited by 59
Pouget, E. R., Fong, C., & Rosenblum, A. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1334070 · Cited by 54
Montoy, J. C. C., Coralic, Z., Herring, A. A., Clattenburg, E. J., & Raven, M. C. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.6544 · Cited by 52
Nosyk, B., Slaunwhite, A., Urbanoski, K., Hongdilokkul, N., Palis, H., Lock, K., Min, J., Zhao, B., Card, K., Barker, B., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-048353 · Cited by 51
Are Pain Management Questions in Patient Satisfaction Surveys Driving the Opioid Epidemic?
Adams, J. M., Bledsoe, G. H., & Armstrong, J. H. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303228 · Cited by 52
Alghnam, S. A., & Castillo, R. C. (2016) · Injury Prevention · doi:10.1136/injuryprev-2016-042059 · Cited by 52
The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review
Pergolizzi, J. V., LeQuang, J. A., Berger, G. K., & Raffa, R. B. (2017) · Pain and Therapy · doi:10.1007/s40122-017-0068-3 · Cited by 60
Peeler, M., Gupta, M., Melvin, P. R., Bryant, A., Diop, H., Iverson, R., Callaghan, K., Wachman, E. M., Singh, R., Houghton, M., et al. (2020) · American Journal of Public Health · doi:10.2105/ajph.2020.305888 · Cited by 52
Pauly, B., Mamdani, Z., Mesley, L., McKenzie, S., Cameron, F., Edwards, D., Howell, A., Knott, M., Scott, T. L., Seguin, R., et al. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.103015 · Cited by 53
Declines in opioid prescribing after a private insurer policy change - Massachusetts, 2011-2015
García, M. C., Dodek, A. B., Kowalski, T., Fallon, J., Lee, S. H., Iademarco, M. F., Auerbach, J., & Bohm, M. K. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6541a1 · Cited by 51
“Overdose deaths involving opioid pain medications are epidemic in the United States, in part because of high opioid prescribing rates and associated abuse of these drugs (1).”
BackgroundIndustry Payments to Physicians for Opioid Products, 2013–2015
Hadland, S. E., Krieger, M. S., & Marshall, B. D. L. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303982 · Cited by 51
Watson, D. P., Ray, B. R., Robison, L., Huynh, P., Sightes, E., Walker, L. S., Brucker, K., & Duwve, J. M. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0226-x · Cited by 51
Identifying gaps in the implementation of naloxone programs for laypersons in the United States
Lambdin, B. H., Zibbell, J. E., Wheeler, E., & Kral, A. H. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.11.017 · Cited by 51
Bossert, J. M., Hoots, J. K., Fredriksson, I., Adhikary, S., Zhang, M., Vènniro, M., & Shaham, Y. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13955 · Cited by 50
“A major obstacle in addressing the current U.S. opioid addiction epidemic is high relapse rates (Rudd et al., 2016; Gostin et al., 2017; Volkow & Collins, 2017).”
BackgroundSingh, S., Kumar, S., Sarkar, S., & Balhara, Y. P. S. (2018) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_171_18 · Cited by 51
State marijuana laws and opioid overdose mortality
Chihuri, S. T., & Li, G. (2019) · Injury Epidemiology · doi:10.1186/s40621-019-0213-z · Cited by 52
“…information is available at the end of the article and continues to present day, characterized by the steady increase in overdose deaths involving illicitly manufactured fentanyl and analogs (Centers for Disease Control and Prevention 2019b; Cicarrone 2017; Rudd et al. 2016b; Seth et al. 2017).”
BackgroundKappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys
Zamarripa, C. A., Naylor, J. E., Huskinson, S. L., Townsend, E. A., Prisinzano, T. E., & Freeman, K. B. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05473-4 · Cited by 51
Crowley, R. S., Riley, A. P., Sherwood, A. M., Groer, C. E., Shivaperumal, N., Biscaia, M., Paton, K. F., Schneider, S. C., Provasi, D., Kivell, B. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01235 · Cited by 50
Managing Opioid Addiction Risk in Plastic Surgery during the Perioperative Period
Demsey, D., Carr, N. J., Clarke, H. A., & Vipler, S. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003742 · Cited by 50
Increasing prevalence of vascular risk factors in patients with stroke
Otite, F. O., Liaw, N., Khandelwal, P., Malik, A. M., Romano, J. G., Rundek, T., Sacco, R. L., & Chaturvedi, S. (2017) · Neurology · doi:10.1212/wnl.0000000000004617 · Cited by 53
Bisaga, A. M., Mannelli, P., Yu, M., Nangia, N., Graham, C. E., Tompkins, D. A., Kosten, T. R., Akerman, S. C., Silverman, B. L., & Sullivan, M. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.02.023 · Cited by 51
Enhanced heroin self-administration and distinct dopamine adaptations in female rats
George, B. E., Barth, S. H., Kuiper, L. B., Holleran, K. M., Lacy, R. T., Raab‐Graham, K. F., & Jones, S. R. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01035-0 · Cited by 52
Regis, C., Gaeta, J. M., Mackin, S., Baggett, T. P., Quinlan, J., & Taveras, E. M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00501 · Cited by 49
“In 2017, 47,600 people died from an opioid overdose in the United States—a 140% increase since 2000 (1, 2).”
BackgroundHowell, B. A., Puglisi, L. B., Clark, K. A. J., Albizu‐García, C. E., Ashkin, E., Booth, T., Brinkley‐Rubinstein, L., Fiellin, D. A., Fox, A. D., Maurer, K. F., et al. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108315 · Cited by 52
Kelly, J. F., Fallah‐Sohy, N., Cristello, J. V., & Bergman, B. G. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.02.010 · Cited by 49
Cryar, K. A., Hereford, T. E., Edwards, P. K., Siegel, E. R., Barnes, C. L., & Mears, S. C. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.03.066 · Cited by 49
Buchheit, T., Zura, R., Wang, Z., Mehta, S., Rocca, G. J. D., & Steen, R. G. (2018) · Injury · doi:10.1016/j.injury.2018.05.004 · Cited by 49
Yi, J. L., Porucznik, C. A., Gren, L. H., Guan, J., Joyce, E. J., Brodke, D. S., Dailey, A. T., Mahan, M. A., Hood, R. S., Lawrence, B. D., et al. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.09.223 · Cited by 49
An Initial evaluation of law enforcement overdose training in Rhode Island
Saucier, C. D., Zaller, N. D., Macmadu, A., & Green, T. C. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.011 · Cited by 48
Cost Utility Analysis of Cervical Therapeutic Medial Branch Blocks in Managing Chronic Neck Pain
Manchikanti, L., Pampati, V., Kaye, A. D., & Hirsch, J. A. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.20755 · Cited by 48
Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study
Merlin, J. S., Young, S. R., Starrels, J. L., Azari, S., Edelman, E. J., Pomeranz, J. L., Roy, P. J., Saini, S., Becker, W. C., & Liebschutz, J. M. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4211-y · Cited by 48
Validation of an Algorithm to Identify Infective Endocarditis in People Who Inject Drugs
Ball, L. J., Sherazi, A., Laczko, D., Gupta, K., Koivu, S. L., Weir, M. A., Mele, T. S., Tirona, R. G., McCormick, J. K., & Silverman, M. (2017) · Medical Care · doi:10.1097/mlr.0000000000000838 · Cited by 48
The Assessment and Management of Pain in Cirrhosis
Klinge, M. J., Coppler, T., Liebschutz, J. M., Dugum, M. F., Wasan, A. D., DiMartini, A. F., & Rogal, S. S. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0389-7 · Cited by 51
An overview of take‐home naloxone programs in Australia
Dwyer, R., Olsen, A., Fowlie, C., Gough, C. M., van Beek, I., JAUNCEY, M. E., Lintzeris, N., Oh, G., Dicka, J., FRY, C. L., et al. (2018) · Drug and Alcohol Review · doi:10.1111/dar.12812 · Cited by 48
COVID-19 and People Who Use Drugs - A Commentary
Walters, S. M. (2020) · Health Behavior and Policy Review · doi:10.14485/hbpr.7.5.11 · Cited by 47
Detectability of fentanyl and designer fentanyls in urine by 3 commercial fentanyl immunoassays
Helander, A., Stojanovic, K., Villén, T., & Beck, O. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2382 · Cited by 47
Opioids in Adolescents’ Homes: Prevalence, Caregiver Attitudes, and Risk Reduction Opportunities
Garbutt, J. M., Kulka, K., Dodd, S., Sterkel, R., & Plax, K. (2018) · Academic Pediatrics · doi:10.1016/j.acap.2018.06.012 · Cited by 46
Weir, M. A., Slater, J., Jandoc, R., Koivu, S. L., Garg, A. X., & Silverman, M. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.180694 · Cited by 47
Impact of the Opioid Epidemic on Heart Transplantation: Donor Characteristics and Organ Discard
Phillips, K. G., Ranganath, N. K., Malas, J., Lonze, B. E., Gidea, C., Smith, D. E., Kon, Z. N., Reyentovich, A., & Moazami, N. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.03.076 · Cited by 47
Risk of reoperative valve surgery for endocarditis associated with drug use
Mori, M., Mahmood, S. U. B., Schranz, A. J., Sultan, I. S., Axtell, A. L., Sarsour, N. Y., Hiesinger, W., Boskovski, M. T., Hirji, S. A., Kaneko, T., et al. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.06.055 · Cited by 47
Bossert, J. M., Kiyatkin, E. A., Korah, H. E., Hoots, J. K., Afzal, A., Perekopskiy, D., Thomas, S. A., Fredriksson, I., Blough, B. E., Negus, S. S., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.014 · Cited by 46
“These three measures model different aspects of human craving and relapse: (1) craving expressed as attraction to drug cues where drugs are not available (37), (2) craving and relapse induced by the drug context after successful extinction of cue reactivity in nondrug settings (38), and (3) craving and continued use i…”
InfluentialUyei, J., Fiellin, D. A., Buchelli, M., Rodriguez-Santana, R., & Braithwaite, R. S. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30006-3 · Cited by 55
Wilson, R. F., Liu, G., Lyons, B. H., Petrosky, E. Y., Harrison, D. D., Betz, C. J., & Blair, J. M. (2022) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss7106a1 · Cited by 46
“Opioid overdose has been recognized as an epidemic (23).”
BackgroundLiu, G. S., Nguyen, B. L., Lyons, B. H., Sheats, K. J., Wilson, R. F., Betz, C. J., & Fowler, K. A. (2023) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss7205a1 · Cited by 47
“In 2017, opioid overdose was recognized as a public health emergency (30) after increases in opioid overdose deaths (31).”
BackgroundThe Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty
Connors, N. J., & Nelson, L. S. (2016) · Journal of Medical Toxicology · doi:10.1007/s13181-016-0559-3 · Cited by 46
“The increase in opioid prescribing was associated with a quadrupling of opioid overdose deaths, from 6242 deaths reported in 2000 to 28,647 in 2014 [2, 3].”
BackgroundPrimary Care Clinic Re-Design for Prescription Opioid Management
Parchman, M. L., Korff, M. V., Baldwin, L., Stephens, M., Ike, B. R., Cromp, D., Hsu, C. W., & Wagner, E. H. (2017) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2017.01.160183 · Cited by 47
The US Opioid Crisis: A Role for Enhanced Recovery After Surgery
Stone, A. B., Wick, E. C., Wu, C. L., & Grant, M. C. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002236 · Cited by 46
Positive Psychology in Lifestyle Medicine and Health Care: Strategies for Implementation
Lianov, L. S., Fredrickson, B. L., Barron, C., Krishnaswami, J., & Wallace, A. (2019) · American Journal of Lifestyle Medicine · doi:10.1177/1559827619838992 · Cited by 50
Weimer, M. B., Morford, K. L., & Donroe, J. H. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00267-x · Cited by 46
Contextually Aided Recovery (CARe): a scientific theory for innate healing
Newell, D., Lothe, L. R., & Raven, T. J. L. (2017) · Chiropractic & Manual Therapies · doi:10.1186/s12998-017-0137-z · Cited by 49
Metadata
- Authors
- Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M.
- Affiliations
- National Center for Injury Prevention and Control (US)
- Venue
- MMWR Morbidity and Mortality Weekly Report
- Published
- 2016-01-01
- Volume
- 64
- Issue
- 50-51
- Pages
- 1378-1382
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2292748019
- Cited by
- 1,859
- References
- 10
- Citations by year
- 2026: 16 · 2025: 35 · 2024: 42 · 2023: 79 · 2022: 118 · 2021: 144 · 2020: 242 · 2019: 271 · 2018: 332 · 2017: 406 · 2016: 169
- FWCI
- 321.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- drug overdose deaths, opioid overdose deaths, opioid epidemic, heroin, illicitly manufactured fentanyl, synthetic opioids, methadone, mortality trends, age-adjusted death rates, opioid use disorder, opioid supply
- MeSH terms
- Adolescent, Adult, Aged, Analgesics, Opioid, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, United States, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review